AbCellera Biologics' GAAP net income for 2021 was $153.464 million, up 29.1% from $118.918 million in the prior year. Revenue increased 60.9% to $375.203 million from $233.155 million a year earlier.
Warning BlackTerminal uses cookies in order to personalize and improve the usability of the service. If you do not want to use cookies, please change your browser settings. Accept